Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis

Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads to a serious deterioration in the quality of life. As a result, studies on the pathophysiology of this disease have led to the development of cytokine-targeted therapies, especially the widespread us...

Full description

Bibliographic Details
Main Authors: Esra Yıldırım Bay, Elif Moustafa, İlteris Oğuz Topal, Özben Yalçın, Naciye Demirel
Format: Article
Language:English
Published: Galenos Publishing House 2021-06-01
Series:Turkderm Turkish Archives of Dermatology and Venereology
Subjects:
Online Access:https://journal.turkderm.org.tr/jvi.aspx?pdir=turkderm&plng=eng&un=TURKDERM-34356&look4=